← Eichor
Condition: Combined Hepatocellular And Cholangiocarcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Combined Hepatocellular And Cholangiocarcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors
NA · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06487663A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers
Phase N/A · 40 location(s) · Federation Francophone de Cancerologie Digestive · NCT06541652The Dragon PLC Trial (DRAGON-PLC)
NA · 55 location(s) · Maastricht University · NCT06914648Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based o
Phase N/A · 1 location(s) · Zhongda Hospital · NCT06849180An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161
Phase 2 · 3 location(s) · Virogin Biotech Canada Ltd · NCT05223816Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition Af
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT03942328DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liv
Phase N/A · 31 location(s) · Maastricht University Medical Center · NCT07717437Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabili
Phase 2 · 1 location(s) · AHS Cancer Control Alberta · NCT05451043HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA)
Phase 2 · 1 location(s) · Fudan University · NCT07105748
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.